MRMD News and Press, MariMed Inc From 04/08/22

Jon DeCourcey from Viridian Capital Advisors returns to discuss recent earnings in the cannabis space and why disappointment is overblown. Favoring quality, underappreciated names due to favorable fundamentals and growth opportunities. The interesting way institutional capital is ...

NORWOOD, Mass., April 07, 2022 (GLOBE NEWSWIRE) -- MariMed, Inc. (OTCQX: MRMD) (“MariMed” or the “Company”), a leading multi-state cannabis operator focused on improving lives every day, today announced that it has filed a preliminary non-offering long form prosp...

Jon DeCourcey from Viridian Capital Advisors returns to discuss recent earnings and why disappointment is overblown. Favoring quality, underappreciated names in the cannabis industry due to favorable fundamentals and growth opportunities. These names also benefit from consolidatio...

Bob Fireman, CEO of MariMed, on transitioning from an advisory firm to a vertically integrated cannabis company. Challenges and risks of expanding into new states; M&A strategies, issuing equity versus debt. Concerns over direct-to-consumer (DTC) sales and how banking or feder...

NORWOOD, Mass., March 23, 2022 (GLOBE NEWSWIRE) -- MariMed, Inc. (OTCQX: MRMD) (“MariMed” or the “Company”), a leading multi-state cannabis operator focused on improving lives every day, today announced its participation in the following cannabis upcoming confere...

Q4 results reflect continued strong execution on 2021 turnaround. Guidance reflects top tier profitability while we believe outstanding acquisitions and investment initiatives will drive share gains and further growth. Estimates unchanged. Believe limited execution risk ongrow...

MariMed Inc. (MRMD) Q4 2021 Earnings Conference Call March 17, 2022, 08:00 AM ET Company Participants Steve West - Vice President of Investor Relations Robert Fireman - President and Chief Executive Officer Jon Levine - Chief Financial Officer and Treasurer Tim Shaw - Chief Operating Officer ...

Norwood, Massachusetts-based cannabis company, MariMed (OTCQX:MRMD) posted better than expected revenue for Q4 2021 on Wednesday and projected guidance ahead of estimates for this year after its annual revenue more than doubled in 2021. Fourth-quarter revenue rose ~52% YoY to $31.0M as revenu...

MariMed press release (OTCQX:MRMD): Q4 Net loss of $6.40M. Revenue of $31.04M (+52.5% Y/Y) beats by $1.78M. For further details see: MariMed net loss of $6.4M, revenue of $31.04M beats by $1.78M

NORWOOD, Mass., March 16, 2022 (GLOBE NEWSWIRE) -- MariMed, Inc. (OTCQX: MRMD) (“MariMed” or the “Company”), a leading multi-state cannabis operator focused on improving lives every day, today announced its financial and operating results for the fourth quarter a...